GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (XTAE:OPK) » Definitions » Cyclically Adjusted PS Ratio

OPKO Health (XTAE:OPK) Cyclically Adjusted PS Ratio : 0.72 (As of May. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is OPKO Health Cyclically Adjusted PS Ratio?

As of today (2024-05-27), OPKO Health's current share price is ₪4.951. OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₪6.90. OPKO Health's Cyclically Adjusted PS Ratio for today is 0.72.

The historical rank and industry rank for OPKO Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

XTAE:OPK' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.48   Med: 4.88   Max: 118.53
Current: 0.71

During the past years, OPKO Health's highest Cyclically Adjusted PS Ratio was 118.53. The lowest was 0.48. And the median was 4.88.

XTAE:OPK's Cyclically Adjusted PS Ratio is ranked better than
80.6% of 134 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.29 vs XTAE:OPK: 0.71

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OPKO Health's adjusted revenue per share data for the three months ended in Mar. 2024 was ₪0.903. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₪6.90 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


OPKO Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for OPKO Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Cyclically Adjusted PS Ratio Chart

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.58 3.43 3.21 0.73 0.81

OPKO Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 1.20 0.87 0.81 0.63

Competitive Comparison of OPKO Health's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, OPKO Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OPKO Health's Cyclically Adjusted PS Ratio falls into.



OPKO Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

OPKO Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=4.951/6.9
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, OPKO Health's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.903/131.7762*131.7762
=0.903

Current CPI (Mar. 2024) = 131.7762.

OPKO Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.209 100.560 0.274
201409 0.170 100.428 0.223
201412 0.217 99.070 0.289
201503 0.248 99.621 0.328
201506 0.337 100.684 0.441
201509 1.019 100.392 1.338
201512 1.871 99.792 2.471
201603 1.959 100.470 2.569
201606 2.355 101.688 3.052
201609 1.983 101.861 2.565
201612 1.091 101.863 1.411
201703 1.753 102.862 2.246
201706 1.905 103.349 2.429
201709 1.616 104.136 2.045
201712 1.057 104.011 1.339
201803 1.674 105.290 2.095
201806 1.731 106.317 2.146
201809 1.640 106.507 2.029
201812 1.421 105.998 1.767
201903 1.394 107.251 1.713
201906 1.418 108.070 1.729
201909 1.433 108.329 1.743
201912 1.323 108.420 1.608
202003 1.213 108.902 1.468
202006 1.728 108.767 2.094
202009 2.455 109.815 2.946
202012 2.836 109.897 3.401
202103 3.125 111.754 3.685
202106 2.512 114.631 2.888
202109 2.175 115.734 2.476
202112 2.261 117.630 2.533
202203 1.832 121.301 1.990
202206 1.598 125.017 1.684
202209 0.880 125.227 0.926
202212 0.906 125.222 0.953
202303 1.161 127.348 1.201
202306 1.297 128.729 1.328
202309 0.873 129.860 0.886
202312 0.889 129.419 0.905
202403 0.903 131.776 0.903

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OPKO Health  (XTAE:OPK) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


OPKO Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of OPKO Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health (XTAE:OPK) Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.